Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.

Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. Abstract Text:

D Micic,M Sumarac-Dumanovic,A Kendereski,G Cvijovic,S Zoric,D Pejkovic,J Micic,N Milic,C Dieguez,F F Casanueva,D Micic,M Sumarac-Dumanovic,A Kendereski,G Cvijovic,S Zoric,D Pejkovic,J Micic,N Milic,C Dieguez,F F Casanueva,D Micic,M Sumarac-Dumanovic,A Kendereski,G Cvijovic,S Zoric,D Pejkovic,J Micic,N Milic,C Dieguez,F F Casanueva,

Controversial data were reported concerning fasting ghrelin (decreased, normal or elevated) in polycystic ovary syndrome (PCOS). The aim of our study was to clarify ghrelin levels in non-obese, overweight, and obese PCOS patients; to investigate the effect of acute insulin infusion on ghrelin in PCOS as a chronic insulin-resistant state, with and without the impact of obesity, and to examine ghrelin-androgen interaction. In that order, we evaluated 1) ghrelin levels among 8 nonobese patients with PCOS [body mass index (BMI): 20.52+/-1.31 kg/m2], 8 overweight and obese patients with PCOS (BMI: 34.36+/-6.53 kg/m2) and their respective controls, 2) ghrelin suppression during euglycemic hyperinsulinemic clamp, and 3) ghrelinandrogen interrelationship. After overnight fast, 2-h euglycemic hyperinsulinemic clamp, was performed in all investigated women. Fasting ghrelin was significantly lower in non-obese PCOS than in controls (64.74+/-25.69 vs 108.36+/-52.60; p<0.05) as well as in overweight and obese PCOS in comparison with controls (38.71+/-14.18 vs 98.77+/-40.49; p<0.05). Insulin infusion significantly suppressed ghrelin in all subgroups of investigated women. Analysis of variance for repeatable measures confirmed that there was no significant difference in pattern of response between PCOS and controls. In conclusion, women with PCOS had lower fasting ghrelin and decreased insulin sensitivity independently of their BMI, compared to the controls. In addition, there were no differences between fasting ghrelin levels among non-obese, overweight, and obese women with PCOS. During euglycemic hyperinsulinemic clamp, ghrelin decreased in all studied groups to a similar extent, implying that, compared to chronic hyperinsulinemia, acute hyperinsulinemia reduces ghrelin levels independently of the degree of insulin resistance.

Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. Publishing Authors By Initials

D Micic,M Sumarac-Dumanovic,A Kendereski,G Cvijovic,S Zoric,D Pejkovic,J Micic,N Milic,C Dieguez,FF Casanueva,D Micic,M Sumarac-Dumanovic,A Kendereski,G Cvijovic,S Zoric,D Pejkovic,J Micic,N Milic,C Dieguez,FF Casanueva,D Micic,M Sumarac-Dumanovic,A Kendereski,G Cvijovic,S Zoric,D Pejkovic,J Micic,N Milic,C Dieguez,FF Casanueva,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of endocrinological investigation

VOLUME: 30

Page Numbers: 820-7

Journal Abbreviation: J. Endocrinol. Invest.

ISSN: 1720-8386

DAY: 13

MONTH: Nov

YEAR: 2007

Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7806594

Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.

AFFILIATION: Center for Metabolic Disorders in Endocrinology, Institute of Endocrinology, Diabetes and Diseases of Metabolism, Clinical Center of Serbia, 11000 Belgrade, Serbia. micicd@eunet.yu.

Country: Italy

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Endocrinol Invest

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome Related Publications

• Combined growth hormone-releasing hormone and growth hormone-releasing peptide-6 test for the evaluation of growth hormone secretion in children with growth hormone deficiency and growth hormone neurosecretory dysfunction.
• Ghrelin and the enteroinsular axis in healthy men.
• Ghrelin: from a GH-secretagogue to the regulation of food intake, sleep and anxiety.
• Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system.
• Growth hormone secretagogues in pathological states: diagnostic implications.
• Influence of metabolic substrates and obesity on growth hormone secretion.
• Leptin, nutrition and reproduction: new insights.
• Lysophosphatidic acid inhibits ghrelin secretion in the human gastric adenocarcinoma AGS cell line - role of mitogenic activated protein kinase signaling pathway.
• Neuropharmacological assessment of growth hormone secretion.
• Pituitary tumorigenesis.
• Risk for postpartum depression, breastfeeding practices, and mammary gland permeability.
• Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin.
• Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.
• [Determining factors in the suspension of breast feeding in a group of urban population]